Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e03573f864c1e834ee1afabce10f4cfd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
filingDate |
2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e40639888698833295b80dc02d15b4e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8088c34e64d53cbc45fd14b48c350f33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8824c1d2957d21f07c55847fa6b47ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c3cdb4968d9d2b9f1859501e633ac16 |
publicationDate |
2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016115137-A1 |
titleOfInvention |
Process for the preparation of erlotinib |
abstract |
A process for the preparation of Erlotinib is disclosed in which the compound of formula (II) n n n n n n n n n n n n Is reacted with the compound of formula (III) n n n n n n n n n n n n n n and the reaction product is subsequently treated with a source of hydrochloric acid in a suitable solvent to give Erlotinib hydrochloride. |
priorityDate |
2014-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |